Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers

Hiddo Jan Lambers Heerspink; David Sjöström; Silvio E Inzucchi; Melissa K Hallow; Valerie A Cain; Peter Rossing; Bergur V Stefansson; Peter Sartipy

Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers

Hiddo Jan Lambers Heerspink, David Sjöström, Silvio E Inzucchi, Melissa K Hallow, Valerie A Cain, Peter Rossing, Bergur V Stefansson, Peter Sartipy

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Artikelnummer	SA-OR081
Tidsskrift	Journal of the American Society of Nephrology
ISSN	1046-6673
Status	Udgivet - 27 okt. 2018
Begivenhed	ASN, Kidney Week, San Diego, US - San Diego, USA Varighed: 25 okt. 2018 → 28 okt. 2018

Konference

Konference	ASN, Kidney Week, San Diego, US
Land/Område	USA
By	San Diego
Periode	25/10/2018 → 28/10/2018

Adgang til dokumentet

https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW18Abstracts.pdf

Citationsformater

Lambers Heerspink, H. J., Sjöström, D., Inzucchi, S. E., Hallow, M. K., Cain, V. A., Rossing, P., Stefansson, B. V., & Sartipy, P. (2018). Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers. Journal of the American Society of Nephrology, Artikel SA-OR081. https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW18Abstracts.pdf

Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers. / Lambers Heerspink, Hiddo Jan; Sjöström, David; Inzucchi, Silvio E et al.
I: Journal of the American Society of Nephrology, 27.10.2018.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Lambers Heerspink, HJ, Sjöström, D, Inzucchi, SE, Hallow, MK, Cain, VA, Rossing, P, Stefansson, BV & Sartipy, P 2018, 'Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers', Journal of the American Society of Nephrology. <https://www.asn-online.org/api/download/?file=/education/kidneyweek/archives/KW18Abstracts.pdf>

@article{6a6e280a859540d0a0affe42bd4be9b7,

title = "Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers",

author = "{Lambers Heerspink}, {Hiddo Jan} and David Sj{\"o}str{\"o}m and Inzucchi, {Silvio E} and Hallow, {Melissa K} and Cain, {Valerie A} and Peter Rossing and Stefansson, {Bergur V} and Peter Sartipy",

year = "2018",

month = oct,

day = "27",

language = "English",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "The American Society of Nephrology",

note = "ASN, Kidney Week, San Diego, US ; Conference date: 25-10-2018 Through 28-10-2018",

}

TY - ABST

T1 - Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers

AU - Lambers Heerspink, Hiddo Jan

AU - Sjöström, David

AU - Inzucchi, Silvio E

AU - Hallow, Melissa K

AU - Cain, Valerie A

AU - Rossing, Peter

AU - Stefansson, Bergur V

AU - Sartipy, Peter

PY - 2018/10/27

Y1 - 2018/10/27

M3 - Conference abstract in journal

SN - 1046-6673

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

M1 - SA-OR081

T2 - ASN, Kidney Week, San Diego, US

Y2 - 25 October 2018 through 28 October 2018

ER -